Founded on the groundbreaking research of Prof. Nissim Garti, Lyotropic Delivery Systems (LDS) emerged as a beacon of innovation in delivery technologies.
Our journey, inspired by Prof. Garti’s pioneering work, has fostered global partnerships, enabled licensing of our technology, supported product commercialization, and propelled clinical studies worldwide, backed by a robust intellectual property portfolio.
Rooted in extensive research and a profound understanding of delivery system science, LDS is committed to advancing novel drug delivery technologies, driving industry evolution, and contributing to global health improvement.
Within our pipeline, we have an array of projects spanning various stages, from early research and development to pre-clinical and clinical studies, all underpinned by a comprehensive intellectual property portfolio.
LDS’s cutting-edge technology has already gained recognition in the industry, with licenses granted to global entities across a spectrum of applications.
These applications encompass a diverse range of active molecules, demonstrating the versatility and adaptability of our technology to meet evolving market needs.
LDS’s technology is rooted in Prof. Garti’s profound understanding of colloids and surfaces, interfacial science, and dispersed systems, studied through decades of dedicated research.
Prof. Garti, a distinguished emeritus full professor at the Hebrew University of Jerusalem, holds the esteemed Ratner Family Chair of Chemistry and is the recipient of numerous international recognitions.
His remarkable contributions have earned global acclaim, including prestigious awards such as the Rockefeller Foundation Award, the International Food Science Award, the American Oil Chemists’ Society (AOCS) Award (twice), the Surfactants in Solution (SIS) Award, and many more, including a lifetime achievement award from the Israel Society for his extensive contributions to fats and oils research and food science.
With a career spanning over three decades, Prof. Garti has served as a consultant to numerous global companies in fields ranging from food chemistry to cosmetics, healthcare, nutraceuticals, and pharmaceuticals.
He has published 15 edited books, over 80 review articles, more than 420 peer-reviewed original scientific manuscripts, and multiple patent applications. He has also served on the scientific boards of various companies and scientific journals.
LDS offers its cutting-edge delivery platform for licensing, aiming to collaborate with companies seeking to enhance their market presence, rejuvenate patents, drive innovation, and overcome traditional delivery system challenges.
LDS Biotech
Hi-Tech Park | Building 5 | Unit 1
Edmond J. Safra Campus
POB 39141
Jerusalem 9139002
Israel